Who has invested in Ascidian Therapeutics?

ATP are named among the investors backing Ascidian Therapeutics.

Ascidian Therapeutics Funding: $50M Raised, Series A (2022)

Ascidian Therapeutics funding overview

Ascidian Therapeutics is based in Boston, MA. Ascidian Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2022. The round record for Ascidian Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include ATP.

Ascidian Therapeutics at a glance

Total raised: $50M
Latest round: Series A
Latest round date: October 2022
Headquarters: Boston, MA
Notable investors: ATP

Frequently asked about Ascidian Therapeutics funding

How much has Ascidian Therapeutics raised?: Ascidian Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Ascidian Therapeutics?: ATP are named among the investors backing Ascidian Therapeutics.
What was the latest Ascidian Therapeutics funding round?: The most recent disclosed round is a Series A, announced in October 2022.
Where is Ascidian Therapeutics based?: Ascidian Therapeutics is based in Boston, MA.
When did Ascidian Therapeutics last raise?: The last disclosed Ascidian Therapeutics round closed in October 2022 at Series A.

We update the Ascidian Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.

Ascidian Therapeutics Funding: $50M Raised, Series A (2022)

Ascidian Therapeutics funding overview

Ascidian Therapeutics at a glance

Frequently asked about Ascidian Therapeutics funding

Companies related to Ascidian Therapeutics (22)

Browse related funding lists (5)